FAQs

Below are frequently asked questions about the Otsuka Patient Assistance Foundation, Inc. If you don’t see your question answered below, please call 1-855-727-6274 for further information.

The Otsuka Patient Assistance Foundation, Inc. is an organization that provides free treatment to eligible uninsured and underinsured patients on ABILIFY® (aripiprazole) Tablets, ABILIFY MAINTENA® (aripiprazole), REXULTI® (brexpiprazole), or SAMSCA® (tolvaptan) medications.

The change demonstrates the commitment Otsuka America Pharmaceutical Inc. (OAPI) has to patients in the U.S. Because the Otsuka Patient Assistance Foundation, Inc. is an independently operated organization it can make a greater impact on patient care, as it provides OAPI further opportunities to offer more services and support.

Patients and healthcare providers can call 1-855-727-6274 to reach the Otsuka Patient Assistance Foundation, Inc.

No. Patients will only need to reapply when it is their normal reenrollment period. The eligibility requirements remain the same. View eligibility requirements >

Yes. Patients must have a diagnosis that is within the drug's approved indication(s) to qualify for no-cost medications from the Otsuka Patient Assistance Foundation, Inc. This means patients who are being treated with Otsuka medications for conditions not indicated in the medication's approved Prescribing Information will not qualify for free treatment. Please contact a Dedicated Patient Case Coordinator by dialing 1-855-727-6274 if further clarification is needed.

Medication will be sent to a patient’s home or their clinician’s office. The location is determined by the medication selection in the enrollment form.

The Otsuka Patient Assistance Foundation, Inc. is funded by donations.

Currently the Otsuka Patient Assistance Foundation, Inc. only provides free medication to eligible patients.

Patients receiving government issued insurance (Medicare, Medicare Part D, Medicaid) need to reapply at the end of every calendar year. Other qualified patients not on a government issued insurance program must reapply every 12 months.

Apply Today

Eligible patients can receive no-cost ABILIFY® (aripiprazole) Tablets, ABILIFY MAINTENA® (aripiprazole), REXULTI® (brexpiprazole), or SAMSCA® (tolvaptan) medications.


Check Patient Eligibility
Download Application
Mail or Fax Form
Apply Now

Otsuka Patient Assistance Foundation, Inc. (OPAF) provides support for the following medications:

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING and MEDICATION GUIDE

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING and MEDICATION GUIDE

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING and MEDICATION GUIDE

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING and MEDICATION GUIDE

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation distributes funds.